Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Cobleskill › NPI 1891862579
Hospital

Bassett Hospital of Schoharie County

Bassett Hospital of Schoharie County was paid $9.95M by Medicaid between Jan 2018 and Nov 2024, across 157 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoBASSETT HOSPITAL OF SCHOHARIE COUNTY
COBLESKILL, NY 12043
33aNPI1891862579assigned 11/29/2006
33bProvider typeRural Acute Care Hospital
28Total paid$9.95M
24GClaims163,319
24DCodes billed157
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in New York

Rank by total paid#5 of 7
Median peer was paid$13.87M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,444$23K
20199,934$345K
202022,611$882K
202131,093$1.43M
202232,751$3.68M
202336,651$2.18M
2024incomplete27,835$1.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 7,992 7,642 $1.87M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.1% 3,040 2,966 $702K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.9% 6,389 5,390 $685K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.7% 3,376 3,243 $563K
80053 Comprehensive metabolic panel 5.4% 8,579 8,076 $539K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.3% 932 921 $526K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.9% 4,358 4,202 $491K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.2% 3,282 3,150 $413K
96361 Intravenous infusion, hydration; each additional hour 3.4% 1,174 1,108 $335K
36415 Collection of venous blood by venipuncture 2.7% 9,900 9,096 $266K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.5% 4,790 1,649 $249K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 2.4% 2,297 2,240 $239K
145 more codes
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.1% 452 $209K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.9% 855 $187K
77067 Screening mammography, bilateral, including computer-aided detection 1.7% 1,429 $165K
81025 1.4% 2,282 $139K
80048 Basic metabolic panel (calcium, ionized) 1.3% 2,739 $126K
70450 Computed tomography, head or brain; without contrast material 1.2% 326 $120K
84443 Thyroid stimulating hormone (TSH) 1.2% 4,882 $116K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 10,743 $112K
80061 Lipid panel 1.1% 4,187 $105K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 247 $99K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,304 $99K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 831 $98K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,344 $88K
95806 <1% 397 $82K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 283 $70K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,368 $67K
83036 Hemoglobin; glycosylated (A1C) <1% 4,221 $65K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 907 $64K
71046 Radiologic examination, chest; 2 views <1% 1,877 $63K
71271 <1% 110 $57K
Q3014 Telehealth originating site facility fee <1% 1,312 $53K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 780 $45K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,974 $39K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,774 $37K
80051 <1% 846 $33K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 265 $33K
86850 <1% 536 $31K
73564 <1% 594 $30K
76830 Ultrasound, transvaginal <1% 154 $29K
73630 <1% 748 $28K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 307 $27K
82607 <1% 1,237 $27K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 354 $26K
84439 <1% 1,620 $26K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 690 $25K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,270 $22K
85027 <1% 1,861 $21K
73610 <1% 634 $19K
73030 <1% 390 $19K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 485 $18K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 781 $17K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 375 $16K
86803 <1% 559 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 83 $14K
86900 <1% 623 $13K
86901 <1% 622 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 543 $12K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 86 $11K
82565 <1% 1,286 $11K
83735 <1% 2,665 $10K
86140 <1% 960 $10K
84450 <1% 1,927 $10K
84466 <1% 642 $10K
83540 <1% 854 $8K
85610 <1% 938 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,121 $8K
82728 <1% 362 $8K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 200 $8K
97161 <1% 76 $7K
84460 <1% 519 $7K
97162 <1% 55 $7K
87086 Culture, bacterial; quantitative colony count, urine <1% 922 $7K
85652 <1% 1,034 $6K
84520 <1% 887 $6K
71045 Radiologic examination, chest; single view <1% 920 $6K
83690 <1% 2,891 $6K
73110 <1% 205 $6K
72110 <1% 55 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 279 $5K
73130 <1% 184 $5K
81003 <1% 1,779 $4K
20610 <1% 27 $4K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 269 $4K
81001 <1% 2,442 $4K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 51 $4K
82570 <1% 270 $3K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 76 $3K
84702 <1% 262 $3K
92567 <1% 111 $2K
83880 <1% 74 $2K
84484 <1% 1,774 $2K
84153 <1% 76 $2K
77080 <1% 13 $2K
86618 <1% 245 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 1,137 $2K
92557 <1% 42 $2K
82947 <1% 507 $2K
80377 <1% 12 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 12 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 42 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 108 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,141 $1K
82247 <1% 1,261 $1K
87634 <1% 49 $1K
83655 <1% 128 $1K
86780 <1% 90 $1K
87340 <1% 66 $1K
17110 <1% 15 $982.25
82040 <1% 1,202 $967.41
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 12 $965.60
83520 <1% 91 $926.07
80076 <1% 16 $824.18
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 59 $770.14
87081 <1% 333 $752.79
90715 <1% 25 $738.78
11721 <1% 25 $626.77
84480 <1% 25 $585.33
82043 <1% 51 $583.76
87476 <1% 32 $533.21
83550 <1% 72 $451.13
90686 <1% 14 $327.76
87468 <1% 12 $326.60
85379 <1% 24 $313.38
84155 <1% 743 $278.87
83605 <1% 126 $274.32
87469 <1% 12 $249.28
87484 <1% 12 $249.28
87478 <1% 12 $249.28
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 89 $201.63
87077 <1% 40 $191.86
82784 <1% 15 $164.91
73590 <1% 12 $159.50
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 103 $159.11
86617 <1% 30 $156.54
86666 <1% 24 $152.50
82950 <1% 13 $150.41
82948 <1% 196 $138.71
86038 <1% 12 $117.08
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 114 $112.41
86753 <1% 13 $92.75
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,015 $86.17
82248 <1% 14 $77.61
J7030 Infusion, normal saline solution , 1000 cc <1% 2,255 $68.54
J3490 Unclassified drugs <1% 59 $68.46
87186 <1% 14 $56.84
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 261 $33.10
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,247 $32.01
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 138 $24.05
J1010 Injection, methylprednisolone acetate, 1 mg <1% 25 $17.91
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 117 $2.38
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 14 $0.62
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 47 $0.10
J7120 Ringers lactate infusion, up to 1000 cc 0% 25 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 59 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARRYOTT, EDWARD (VICE PRESIDENT OF REVENUE CYCLE)